SCIENION AG and GENOMICA S.A.U have announced the launch of multiplex CE-IVD tests for sexually transmitted infections (STIs), CLART® STI A&B. According to recent estimates, the global incidence rate ...

Specialist in Low-Volume Liquid Handling Helps Bring Multiplexing to Lateral Flow and TEM Scienion is introducing multiplexing to both lateral flow diagnostic rapid tests and transmission electron ...

Founded in 2001, Scienion is a successful specialist in the sector for dispensing liquids in the nano and picoliter range. Using Scienion's dispensing systems, similar to an inkjet printer, customers ...

Targets markets include oncology, autoimmune, allergy, immunoassay, infectious disease and others. It will provide commercialization partners with a scalable offering to address emerging diagnostic ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Scienion will produce protein microarrays using its sciFlexArrayer. Scienion will produce protein microarray batches for clinical validation of Protagen’s multiplex diagnostic biomarker panels for the ...

Scienion and the University of California San Diego have developed a tool that allows scientists to see, at the scale of five billionths of a meter, 'nanoscale' mixing processes in liquids for the ...

In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem, and how it will bring new flexibility to the manufacturing ...

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance Auckland-based ...

The positions in the table below reflect the Scienion AG's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...